HEADER OXIDOREDUCTASE 04-JAN-02 1KQC TITLE STRUCTURE OF NITROREDUCTASE FROM E. CLOACAE COMPLEX WITH INHIBITOR TITLE 2 ACETATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 1.6.6.-; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTER CLOACAE; SOURCE 3 ORGANISM_TAXID: 550; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET24D(+) KEYWDS NITROREDUCTASE, FLAVIN, ACETATE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.A.HAYNES,R.L.KODER,A.F.MILLER,D.W.RODGERS REVDAT 5 14-FEB-24 1KQC 1 REMARK REVDAT 4 11-OCT-17 1KQC 1 REMARK REVDAT 3 24-FEB-09 1KQC 1 VERSN REVDAT 2 03-APR-02 1KQC 1 JRNL REMARK REVDAT 1 13-FEB-02 1KQC 0 JRNL AUTH C.A.HAYNES,R.L.KODER,A.F.MILLER,D.W.RODGERS JRNL TITL STRUCTURES OF NITROREDUCTASE IN THREE STATES: EFFECTS OF JRNL TITL 2 INHIBITOR BINDING AND REDUCTION. JRNL REF J.BIOL.CHEM. V. 277 11513 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11805110 JRNL DOI 10.1074/JBC.M111334200 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 59095 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.150 REMARK 3 FREE R VALUE TEST SET COUNT : 5998 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6708 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 140 REMARK 3 SOLVENT ATOMS : 449 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KQC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-02. REMARK 100 THE DEPOSITION ID IS D_1000015227. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-NOV-00 REMARK 200 TEMPERATURE (KELVIN) : 115 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : GRADED MULTI-LAYER REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59095 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 0.8 REMARK 200 DATA REDUNDANCY : 4.770 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 0.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.28 REMARK 200 R MERGE FOR SHELL (I) : 0.27800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HOMOPIPES, ACETATE, PEG 4000, PH 4.8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.80300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMER. CHAINS A AND B REPRESENT ONE DIMER, REMARK 300 CHAINS C AND D REPRESENT THE OTHER DIMER; BOTH REMARK 300 DIMERS ARE IN THE ASYMMETRIC UNIT. WE ARE REMARK 300 DEPOSITING ALL FOUR MONOMERS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 465 MET C 1 REMARK 465 MET D 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 41 19.41 58.17 REMARK 500 GLN A 44 56.46 36.12 REMARK 500 VAL A 130 -63.96 -92.65 REMARK 500 ASP A 198 85.19 -67.13 REMARK 500 THR B 41 18.06 55.91 REMARK 500 GLN B 44 53.28 33.87 REMARK 500 THR C 41 18.53 57.74 REMARK 500 GLN C 44 55.79 34.87 REMARK 500 VAL C 130 -68.04 -101.65 REMARK 500 ASP C 134 30.08 -140.81 REMARK 500 ASP C 198 99.39 -67.79 REMARK 500 THR D 41 16.94 58.02 REMARK 500 GLN D 44 56.85 37.01 REMARK 500 PRO D 45 49.79 -80.46 REMARK 500 ARG D 129 -79.65 -95.42 REMARK 500 ASP D 131 -123.81 -63.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 522 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 523 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D 524 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C 525 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 518 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 519 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN C 520 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN D 521 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KQB RELATED DB: PDB REMARK 900 STRUCTURE OF NITROREDUCTASE FROM E. CLOACAE COMPLEX WITH INHIBITOR REMARK 900 BENZOATE REMARK 900 RELATED ID: 1KQD RELATED DB: PDB REMARK 900 STRUCTURE OF NITROREDUCTASE FROM E. CLOACAE BOUND WITH 2E- REDUCED REMARK 900 FLAVIN MONONUCLEOTIDE (FMN) DBREF 1KQC A 1 217 UNP Q01234 NFNB_ENTCL 1 217 DBREF 1KQC B 1 217 UNP Q01234 NFNB_ENTCL 1 217 DBREF 1KQC C 1 217 UNP Q01234 NFNB_ENTCL 1 217 DBREF 1KQC D 1 217 UNP Q01234 NFNB_ENTCL 1 217 SEQRES 1 A 217 MET ASP ILE ILE SER VAL ALA LEU LYS ARG HIS SER THR SEQRES 2 A 217 LYS ALA PHE ASP ALA SER LYS LYS LEU THR ALA GLU GLU SEQRES 3 A 217 ALA GLU LYS ILE LYS THR LEU LEU GLN TYR SER PRO SER SEQRES 4 A 217 SER THR ASN SER GLN PRO TRP HIS PHE ILE VAL ALA SER SEQRES 5 A 217 THR GLU GLU GLY LYS ALA ARG VAL ALA LYS SER ALA ALA SEQRES 6 A 217 GLY THR TYR VAL PHE ASN GLU ARG LYS MET LEU ASP ALA SEQRES 7 A 217 SER HIS VAL VAL VAL PHE CYS ALA LYS THR ALA MET ASP SEQRES 8 A 217 ASP ALA TRP LEU GLU ARG VAL VAL ASP GLN GLU GLU ALA SEQRES 9 A 217 ASP GLY ARG PHE ASN THR PRO GLU ALA LYS ALA ALA ASN SEQRES 10 A 217 HIS LYS GLY ARG THR TYR PHE ALA ASP MET HIS ARG VAL SEQRES 11 A 217 ASP LEU LYS ASP ASP ASP GLN TRP MET ALA LYS GLN VAL SEQRES 12 A 217 TYR LEU ASN VAL GLY ASN PHE LEU LEU GLY VAL GLY ALA SEQRES 13 A 217 MET GLY LEU ASP ALA VAL PRO ILE GLU GLY PHE ASP ALA SEQRES 14 A 217 ALA ILE LEU ASP GLU GLU PHE GLY LEU LYS GLU LYS GLY SEQRES 15 A 217 PHE THR SER LEU VAL VAL VAL PRO VAL GLY HIS HIS SER SEQRES 16 A 217 VAL GLU ASP PHE ASN ALA THR LEU PRO LYS SER ARG LEU SEQRES 17 A 217 PRO LEU SER THR ILE VAL THR GLU CYS SEQRES 1 B 217 MET ASP ILE ILE SER VAL ALA LEU LYS ARG HIS SER THR SEQRES 2 B 217 LYS ALA PHE ASP ALA SER LYS LYS LEU THR ALA GLU GLU SEQRES 3 B 217 ALA GLU LYS ILE LYS THR LEU LEU GLN TYR SER PRO SER SEQRES 4 B 217 SER THR ASN SER GLN PRO TRP HIS PHE ILE VAL ALA SER SEQRES 5 B 217 THR GLU GLU GLY LYS ALA ARG VAL ALA LYS SER ALA ALA SEQRES 6 B 217 GLY THR TYR VAL PHE ASN GLU ARG LYS MET LEU ASP ALA SEQRES 7 B 217 SER HIS VAL VAL VAL PHE CYS ALA LYS THR ALA MET ASP SEQRES 8 B 217 ASP ALA TRP LEU GLU ARG VAL VAL ASP GLN GLU GLU ALA SEQRES 9 B 217 ASP GLY ARG PHE ASN THR PRO GLU ALA LYS ALA ALA ASN SEQRES 10 B 217 HIS LYS GLY ARG THR TYR PHE ALA ASP MET HIS ARG VAL SEQRES 11 B 217 ASP LEU LYS ASP ASP ASP GLN TRP MET ALA LYS GLN VAL SEQRES 12 B 217 TYR LEU ASN VAL GLY ASN PHE LEU LEU GLY VAL GLY ALA SEQRES 13 B 217 MET GLY LEU ASP ALA VAL PRO ILE GLU GLY PHE ASP ALA SEQRES 14 B 217 ALA ILE LEU ASP GLU GLU PHE GLY LEU LYS GLU LYS GLY SEQRES 15 B 217 PHE THR SER LEU VAL VAL VAL PRO VAL GLY HIS HIS SER SEQRES 16 B 217 VAL GLU ASP PHE ASN ALA THR LEU PRO LYS SER ARG LEU SEQRES 17 B 217 PRO LEU SER THR ILE VAL THR GLU CYS SEQRES 1 C 217 MET ASP ILE ILE SER VAL ALA LEU LYS ARG HIS SER THR SEQRES 2 C 217 LYS ALA PHE ASP ALA SER LYS LYS LEU THR ALA GLU GLU SEQRES 3 C 217 ALA GLU LYS ILE LYS THR LEU LEU GLN TYR SER PRO SER SEQRES 4 C 217 SER THR ASN SER GLN PRO TRP HIS PHE ILE VAL ALA SER SEQRES 5 C 217 THR GLU GLU GLY LYS ALA ARG VAL ALA LYS SER ALA ALA SEQRES 6 C 217 GLY THR TYR VAL PHE ASN GLU ARG LYS MET LEU ASP ALA SEQRES 7 C 217 SER HIS VAL VAL VAL PHE CYS ALA LYS THR ALA MET ASP SEQRES 8 C 217 ASP ALA TRP LEU GLU ARG VAL VAL ASP GLN GLU GLU ALA SEQRES 9 C 217 ASP GLY ARG PHE ASN THR PRO GLU ALA LYS ALA ALA ASN SEQRES 10 C 217 HIS LYS GLY ARG THR TYR PHE ALA ASP MET HIS ARG VAL SEQRES 11 C 217 ASP LEU LYS ASP ASP ASP GLN TRP MET ALA LYS GLN VAL SEQRES 12 C 217 TYR LEU ASN VAL GLY ASN PHE LEU LEU GLY VAL GLY ALA SEQRES 13 C 217 MET GLY LEU ASP ALA VAL PRO ILE GLU GLY PHE ASP ALA SEQRES 14 C 217 ALA ILE LEU ASP GLU GLU PHE GLY LEU LYS GLU LYS GLY SEQRES 15 C 217 PHE THR SER LEU VAL VAL VAL PRO VAL GLY HIS HIS SER SEQRES 16 C 217 VAL GLU ASP PHE ASN ALA THR LEU PRO LYS SER ARG LEU SEQRES 17 C 217 PRO LEU SER THR ILE VAL THR GLU CYS SEQRES 1 D 217 MET ASP ILE ILE SER VAL ALA LEU LYS ARG HIS SER THR SEQRES 2 D 217 LYS ALA PHE ASP ALA SER LYS LYS LEU THR ALA GLU GLU SEQRES 3 D 217 ALA GLU LYS ILE LYS THR LEU LEU GLN TYR SER PRO SER SEQRES 4 D 217 SER THR ASN SER GLN PRO TRP HIS PHE ILE VAL ALA SER SEQRES 5 D 217 THR GLU GLU GLY LYS ALA ARG VAL ALA LYS SER ALA ALA SEQRES 6 D 217 GLY THR TYR VAL PHE ASN GLU ARG LYS MET LEU ASP ALA SEQRES 7 D 217 SER HIS VAL VAL VAL PHE CYS ALA LYS THR ALA MET ASP SEQRES 8 D 217 ASP ALA TRP LEU GLU ARG VAL VAL ASP GLN GLU GLU ALA SEQRES 9 D 217 ASP GLY ARG PHE ASN THR PRO GLU ALA LYS ALA ALA ASN SEQRES 10 D 217 HIS LYS GLY ARG THR TYR PHE ALA ASP MET HIS ARG VAL SEQRES 11 D 217 ASP LEU LYS ASP ASP ASP GLN TRP MET ALA LYS GLN VAL SEQRES 12 D 217 TYR LEU ASN VAL GLY ASN PHE LEU LEU GLY VAL GLY ALA SEQRES 13 D 217 MET GLY LEU ASP ALA VAL PRO ILE GLU GLY PHE ASP ALA SEQRES 14 D 217 ALA ILE LEU ASP GLU GLU PHE GLY LEU LYS GLU LYS GLY SEQRES 15 D 217 PHE THR SER LEU VAL VAL VAL PRO VAL GLY HIS HIS SER SEQRES 16 D 217 VAL GLU ASP PHE ASN ALA THR LEU PRO LYS SER ARG LEU SEQRES 17 D 217 PRO LEU SER THR ILE VAL THR GLU CYS HET ACT A 522 4 HET FMN A 518 31 HET ACT B 523 4 HET FMN B 519 31 HET ACT C 525 4 HET FMN C 520 31 HET ACT D 524 4 HET FMN D 521 31 HETNAM ACT ACETATE ION HETNAM FMN FLAVIN MONONUCLEOTIDE HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 5 ACT 4(C2 H3 O2 1-) FORMUL 6 FMN 4(C17 H21 N4 O9 P) FORMUL 13 HOH *449(H2 O) HELIX 1 1 ASP A 2 ARG A 10 1 9 HELIX 2 2 THR A 23 TYR A 36 1 14 HELIX 3 3 SER A 39 SER A 43 5 5 HELIX 4 4 THR A 53 ALA A 61 1 9 HELIX 5 5 LYS A 62 ALA A 64 5 3 HELIX 6 6 ALA A 65 PHE A 70 5 6 HELIX 7 7 ASN A 71 ALA A 78 1 8 HELIX 8 8 ASP A 91 ASP A 105 1 15 HELIX 9 9 THR A 110 VAL A 130 1 21 HELIX 10 10 ASP A 134 MET A 157 1 24 HELIX 11 11 ASP A 168 PHE A 176 1 9 HELIX 12 12 GLY A 177 GLY A 182 1 6 HELIX 13 13 ASP A 198 THR A 202 5 5 HELIX 14 14 PRO A 209 ILE A 213 1 5 HELIX 15 15 ASP B 2 ARG B 10 1 9 HELIX 16 16 THR B 23 TYR B 36 1 14 HELIX 17 17 SER B 39 SER B 43 5 5 HELIX 18 18 THR B 53 LYS B 62 1 10 HELIX 19 19 SER B 63 ALA B 64 5 2 HELIX 20 20 ALA B 65 PHE B 70 5 6 HELIX 21 21 ASN B 71 ALA B 78 1 8 HELIX 22 22 ASP B 91 ASP B 105 1 15 HELIX 23 23 THR B 110 VAL B 130 1 21 HELIX 24 24 ASP B 134 MET B 157 1 24 HELIX 25 25 ASP B 168 PHE B 176 1 9 HELIX 26 26 GLY B 177 GLY B 182 1 6 HELIX 27 27 ASP B 198 THR B 202 5 5 HELIX 28 28 PRO B 209 ILE B 213 1 5 HELIX 29 29 ASP C 2 ARG C 10 1 9 HELIX 30 30 THR C 23 TYR C 36 1 14 HELIX 31 31 SER C 39 SER C 43 5 5 HELIX 32 32 THR C 53 LYS C 62 1 10 HELIX 33 33 SER C 63 PHE C 70 5 8 HELIX 34 34 ASN C 71 ALA C 78 1 8 HELIX 35 35 ASP C 91 ASP C 105 1 15 HELIX 36 36 THR C 110 VAL C 130 1 21 HELIX 37 37 ASP C 134 MET C 157 1 24 HELIX 38 38 ASP C 168 PHE C 176 1 9 HELIX 39 39 GLY C 177 GLY C 182 1 6 HELIX 40 40 PRO C 209 ILE C 213 1 5 HELIX 41 41 ASP D 2 ARG D 10 1 9 HELIX 42 42 THR D 23 TYR D 36 1 14 HELIX 43 43 SER D 39 SER D 43 5 5 HELIX 44 44 THR D 53 LYS D 62 1 10 HELIX 45 45 SER D 63 ALA D 64 5 2 HELIX 46 46 ALA D 65 PHE D 70 5 6 HELIX 47 47 ASN D 71 ALA D 78 1 8 HELIX 48 48 ASP D 91 ASP D 105 1 15 HELIX 49 49 THR D 110 MET D 127 1 18 HELIX 50 50 ASP D 134 MET D 157 1 24 HELIX 51 51 ASP D 168 PHE D 176 1 9 HELIX 52 52 GLY D 177 GLY D 182 1 6 HELIX 53 53 ASP D 198 THR D 202 5 5 HELIX 54 54 PRO D 209 ILE D 213 1 5 SHEET 1 A 5 ASP A 160 ALA A 161 0 SHEET 2 A 5 PHE A 183 GLY A 192 -1 O GLY A 192 N ASP A 160 SHEET 3 A 5 HIS A 80 LYS A 87 -1 N VAL A 82 O VAL A 189 SHEET 4 A 5 TRP A 46 ALA A 51 -1 N ILE A 49 O VAL A 83 SHEET 5 A 5 VAL B 214 CYS B 217 1 O THR B 215 N VAL A 50 SHEET 1 B 5 VAL A 214 CYS A 217 0 SHEET 2 B 5 TRP B 46 ALA B 51 1 O VAL B 50 N THR A 215 SHEET 3 B 5 HIS B 80 LYS B 87 -1 O VAL B 81 N ALA B 51 SHEET 4 B 5 PHE B 183 GLY B 192 -1 O VAL B 189 N VAL B 82 SHEET 5 B 5 ASP B 160 ALA B 161 -1 N ASP B 160 O GLY B 192 SHEET 1 C 5 ASP C 160 ALA C 161 0 SHEET 2 C 5 PHE C 183 GLY C 192 -1 O GLY C 192 N ASP C 160 SHEET 3 C 5 HIS C 80 LYS C 87 -1 N HIS C 80 O VAL C 191 SHEET 4 C 5 TRP C 46 ALA C 51 -1 N ALA C 51 O VAL C 81 SHEET 5 C 5 VAL D 214 CYS D 217 1 O THR D 215 N PHE C 48 SHEET 1 D 5 VAL C 214 CYS C 217 0 SHEET 2 D 5 TRP D 46 ALA D 51 1 O PHE D 48 N THR C 215 SHEET 3 D 5 HIS D 80 LYS D 87 -1 O VAL D 83 N ILE D 49 SHEET 4 D 5 PHE D 183 GLY D 192 -1 O VAL D 191 N HIS D 80 SHEET 5 D 5 ASP D 160 ALA D 161 -1 N ASP D 160 O GLY D 192 SITE 1 AC1 4 THR A 41 PHE A 124 HOH A 603 FMN B 519 SITE 1 AC2 6 FMN A 518 SER B 40 THR B 41 PHE B 124 SITE 2 AC2 6 HOH B 540 HOH B 615 SITE 1 AC3 3 FMN C 520 THR D 41 PHE D 124 SITE 1 AC4 4 THR C 41 PHE C 124 HOH C 528 FMN D 521 SITE 1 AC5 25 ARG A 10 HIS A 11 SER A 12 LYS A 14 SITE 2 AC5 25 ASN A 71 LYS A 74 TYR A 144 PRO A 163 SITE 3 AC5 25 ILE A 164 GLU A 165 GLY A 166 LYS A 205 SITE 4 AC5 25 ARG A 207 HOH A 536 HOH A 537 HOH A 543 SITE 5 AC5 25 HOH A 554 PRO B 38 SER B 39 SER B 40 SITE 6 AC5 25 ASN B 42 GLN B 142 LEU B 145 ACT B 523 SITE 7 AC5 25 HOH B 540 SITE 1 AC6 24 PRO A 38 SER A 39 SER A 40 ASN A 42 SITE 2 AC6 24 LEU A 145 ACT A 522 ARG B 10 HIS B 11 SITE 3 AC6 24 SER B 12 LYS B 14 PHE B 70 ASN B 71 SITE 4 AC6 24 LYS B 74 TYR B 144 PRO B 163 ILE B 164 SITE 5 AC6 24 GLU B 165 GLY B 166 LYS B 205 ARG B 207 SITE 6 AC6 24 HOH B 524 HOH B 532 HOH B 535 HOH B 543 SITE 1 AC7 24 ARG C 10 HIS C 11 SER C 12 LYS C 14 SITE 2 AC7 24 ASN C 71 LYS C 74 TYR C 144 PRO C 163 SITE 3 AC7 24 ILE C 164 GLU C 165 GLY C 166 LYS C 205 SITE 4 AC7 24 ARG C 207 HOH C 539 HOH C 559 HOH C 570 SITE 5 AC7 24 HOH C 585 PRO D 38 SER D 39 SER D 40 SITE 6 AC7 24 ASN D 42 GLN D 142 LEU D 145 ACT D 524 SITE 1 AC8 24 PRO C 38 SER C 39 SER C 40 ASN C 42 SITE 2 AC8 24 LEU C 145 ACT C 525 HOH C 528 ARG D 10 SITE 3 AC8 24 HIS D 11 SER D 12 LYS D 14 ASN D 71 SITE 4 AC8 24 LYS D 74 TYR D 144 PRO D 163 ILE D 164 SITE 5 AC8 24 GLU D 165 GLY D 166 LYS D 205 ARG D 207 SITE 6 AC8 24 HOH D 529 HOH D 532 HOH D 539 HOH D 553 CRYST1 52.785 79.606 97.138 90.00 93.63 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018945 0.000000 0.001202 0.00000 SCALE2 0.000000 0.012562 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010315 0.00000